Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Pilot Tape Harvesting Study
Biogen completed a pilot tape-harvesting study evaluating tape-stripping methods in subjects with Atopic Dermatitis, Discoid Lupus Erythemat…
-
CLINICAL_TRIALS research · 2016-09-22Clinical Trial Update: The Natural History of Atopic Disease in Thai Children and Association With Atopic March
A completed observational study by Mahidol University examining the natural history of atopic diseases in Thai children, focusing on atopic …
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis [Phase 2]
Phase 2 study updating the safety and efficacy of PAC-14028 Cream in adults with atopic dermatitis; the trial has been completed.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Runzao Zhiyang Capsule for chronic eczema.
-
CLINICAL_TRIALS withdrawal · 2016-09-16Clinical Trial Update: The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis [NA]
The clinical trial evaluating polyunsaturated fatty acids for atopic dermatitis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young Patients [NA]
This document reports the completion of a clinical trial evaluating a probiotic intervention for mild atopic dermatitis in young patients.
-
CLINICAL_TRIALS withdrawal · 2016-09-09Clinical Trial Update: Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older [Phase 3]
The Phase 3 study of MSRD-100 in subjects with atopic dermatitis has been withdrawn. The sponsor is Merz North America, Inc.
-
CLINICAL_TRIALS withdrawal · 2016-09-09Clinical Trial Update: Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older [Phase 3]
A Phase 3 study evaluating MSRD-100 for atopic dermatitis was withdrawn, and the trial is no longer active.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD) [Phase 1]
Open-label Phase 1 study assessing potential drug-drug interactions with dupilumab in adults with moderate-to-severe atopic dermatitis; the …
-
FDA approval · 2016-08-05FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the Original Application (ANDA) for Triamcinolone Acetonide, a generic product manufactured by Glenmark Pharmaceuticals Inc., U…
-
FDA approval · 2016-07-28FDA Approved: PSORCON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for PSORCON (diflorasone diacetate) filed by Sun Pharmaceutical Industries, likely updating labeling…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis [Phase 2]
Phase 2 pharmacodynamics update of Omiganan (CLS001) in patients with atopic dermatitis, providing pharmacodynamic data from the study.
-
FDA approval · 2016-07-22FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's generic Triamcinolone Acetonide under Original Application (ANDA 206379) for topical corticosteroid use in inflammat…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy [NA]
This document provides an update on the results of a clinical trial evaluating a regularly applied emollient spray for Atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003) [Phase 1]
Phase 1 study of intravenous MK-8226 in moderate-to-severe atopic dermatitis was terminated; results posted in 2016.
-
FDA approval · 2016-06-08FDA Approved: DESONIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for DESONIDE submitted by Padagis Israel Pharmaceuticals Ltd, resulting in labeling changes for …
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin [Phase 1]
A Phase 1 clinical trial update reports completion of a 47-hour occlusive cutaneous patch test in adults with dry/atopic skin (eczema). The …
-
FDA approval · 2016-05-19FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' fluocinonide acetonide topical product through an original generic application (ANDA).
-
FDA approval · 2016-05-19FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' fluocinonide acetonide topical product as an original application (ANDA 202368). The generic top…
-
FDA approval · 2016-05-12FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., authorizing changes to the approved produc…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases [Phase 2]
This update summarizes Phase 2 efficacy results from a study comparing two phototherapy approaches for atopic dermatitis and psoriasis, and …
-
FDA approval · 2016-05-10FDA Approved: DESOXIMETASONE — Original Application (Novel Laboratories, Inc.)
FDA approves a generic topical desoximetasone from Novel Laboratories, Inc. under an Original Application (ANDA 206792).
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% [Phase 2]
Phase 2 trial of MRX-6 Cream 2% for atopic dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Atopy Patch Test in Children With Atopic Dermatitis
A completed clinical trial evaluating the use of the atopy patch test in children with atopic dermatitis to assess allergen sensitivity.
-
FDA approval · 2016-04-25FDA Approved: FLUOCINOLONE ACETONIDE OIL — Original Application (Rising Pharma Holdings, Inc.)
FDA approves Rising Pharma Holdings' Fluocinonide Acetonide Oil as a generic topical corticosteroid for inflammatory and pruritic skin condi…